Nucleus Biologics
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Nucleus Biologics is a biotechnology company that provides custom cell culture media, buffers, and reagents for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleus Biologics Comparables
Compare Nucleus Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gemini Bioproducts, LLC | 85% | |
| Ampersand Capital Partners | 81% | |
| RoosterBio | 78% |
Nucleus Biologics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 129% MoM, reaching 5.7K.
- Dec 9, 2025
Monthly visitors grew 31% MoM, reaching 3.4K.
Nucleus Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nucleus Biologics's valuation, stock price, and market status.
Is Nucleus Biologics a public or private company?
Nucleus Biologics is a private company.
What is the current stock price of Nucleus Biologics?
Nucleus Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Nucleus Biologics worth (valuation)?
Valuation information for Nucleus Biologics is not publicly available.
Can I buy Nucleus Biologics stock?
Nucleus Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nucleus Biologics's last funding round?
Funding round information for Nucleus Biologics is not publicly available.
Who are the main investors in Nucleus Biologics?
Investor information for Nucleus Biologics is not publicly disclosed.
Will Nucleus Biologics IPO soon?
No public IPO plans have been announced for Nucleus Biologics.
How can I track Nucleus Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nucleus Biologics's secondary market activity and sign up for updates.